Financials

  • Market Capitalization 2.11 B
  • Employee 398
  • Founded 1989
  • CEO Nick Colangelo
  • Website www.vcel.com
  • Headquarter Michigan, United States
  • FIGI BBG000BDCM24
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
112.53
Price to sales ratio
6.8

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1974
ZBIO
Zenas BioPharma, Inc. - Common Stock
32.62 USD-1.27%+2.48%+0.59%+23.28%2.13 B USD
1975
ADMA
ADMA Biologics Inc - Common Stock
9.48 USD-1.56%-3.07%+8.84%-45.52%2.12 B USD
1984
STOK
Stoke Therapeutics, Inc. - Common Stock
32.59 USD-1.51%+2.61%+10.74%+62.95%2.10 B USD
1999
ZYME
Zymeworks Inc. - Common Stock
29.01 USD-1.02%+7.44%+28.02%+63.53%2.06 B USD

Frequently asked questions about Vericel Corporation

What is the Vericel Corporation stock price today?

The current price of Vericel Corporation (VCEL) is 41.18. Over the past 24 hours, the stock has changed by -2.97%. Follow the VCEL chart for real-time price dynamics.

What is the stock ticker of Vericel Corporation?

Vericel Corporation trades under the ticker VCEL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Vericel Corporation stock going up?

VCEL has changed by -2.79% over the last week, -11.61% over the last month, and +13.29% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Vericel Corporation?

Vericel Corporation currently has a market capitalization of 2.11 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Vericel Corporation earnings last quarter?

Last quarter, Vericel Corporation reported earnings of 0.04 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Vericel Corporation revenue for the last quarter?

Vericel Corporation reported quarterly revenue of 77.46 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Vericel Corporation net income for the last quarter?

Vericel Corporation reported net income of 2.21 M for the last quarter. The previous quarter showed -6.3 M, which means net income changed by +135.00%.

How many employees does Vericel Corporation have?

As of the latest available data, Vericel Corporation has 398 employees. Workforce size can provide additional context about the company's scale and operations.

What is Vericel Corporation EBITDA?

Vericel Corporation EBITDA is 4.05 M, and its EBITDA margin is 5.23%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Vericel Corporation stock?

You can buy Vericel Corporation (VCEL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Vericel Corporation stock?

Investing in Vericel Corporation requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VCEL chart and related analysis on metatrader.com as part of your research.

Vericel Corporation - Common Stock

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan. In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before. In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts.

News